Thrombosis
Conference Coverage
TAILOR-PCI: Clopidogrel genotyping trial narrowly misses endpoint
The trial missed its ambitious primary endpoint of a 50% reduction in cardiovascular events, but experts felt that it still should change practice...
Conference Coverage
Rivaroxaban plus aspirin safely benefits PAD patients after limb revascularization
Conference Coverage
Anticoagulants may have advantage over aspirin for low-risk TAVR
NATIONAL HARBOR, MD. – Anticoagulant therapy is found superior to antiplatelet therapy for preventing leaflet thrombosis after TAVR.
Conference Coverage
AUGUSTUS: Apixaban surpassed warfarin despite prior stroke or thromboembolism
LOS ANGELES – Secondary AUGUSTUS analysis showed ACS/PCI patients with AFib plus prior stroke, TIA, or thromboembolism did better on apixaban.
Conference Coverage
AFib patients do best on a DOAC started 7-10 days post stroke
LOS ANGELES – Observational data hints at the best time to start oral anticoagulation in AFib patients after a cardioembolic stroke.
Conference Coverage
After PCI, stopping antiplatelet therapy for surgery appears safe
NATIONAL HARBOR, MD. –
Conference Coverage
TNK dose in large-vessel stroke: 0.25 mg/kg is sufficient
New data from a second EXTEND-IA TNK (tenecteplase) trial clarify the optimum dose of the bolus thrombolytic for use in ischemic stroke.
Conference Coverage
What 2019’s top five CAD trials tell us
SNOWMASS, COLO. – Triple therapy as a triple threat – a three-pronged threat to patient safety, Dr. Malcolm R. Bell says.
Conference Coverage
Vigilance safely keeps AFib patients off anticoagulants post ablation
NATIONAL HARBOR, MD. – One U.S. center uses frequent monitoring to allow selected AFib patients to safely stop anticoagulation after catheter...
Conference Coverage
Are providers asking about menstrual bleeding before/during anticoagulant therapy?
Conference Coverage
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.